跳至主要内容
临床试验/NL-OMON24239
NL-OMON24239招募中不适用

Fecal microbiota transplantation for improved Fructose catabolism and Insulin sensiTivity In patients with metabolic syndrome

Amsterdam UMC0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
48

研究概览

简要总结

n/a

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria metabolic syndrome subjects:
  • Treatment naïve (no medication use)
  • Metabolic syndrome (3 out of 5 NCEP ATPIII criteria with at least fasting glucose = 5.6 mmol/l)
  • Aged 18-70 years
  • BMI = 25kg/m2
  • Low gut microbiome diversity in 3 baseline fecal samples taken during 1 week (average Shannon diversity 4.2 or lower)
  • Male/postmenopausal females
  • South Asian Surinamese (SAS) or Caucasian descent
  • Inclusion criteria fecal donors:
  • Treatment naïve (no medication use)
  • Normal fasting glucose and lipid levels
  • aged 18-70 years
  • BMI < 25kg/m2
  • Male / female gender
  • High microbiota diversity in 3 fecal samples taken during 1 week (average Shannon 4.2 or higher) with presence of
  • Desulfovibrio strains
  • South Asian Surinamese (SAS) or Caucasian descent

排除标准

  • Exclusion criteria metabolic syndrome subjects/donors:
  • Inability to provide written informed consent
  • Antibiotics use in the last 3 months and proton-pump inhibitor use
  • Alcohol or nicotine abuse
  • Evidence for compromised immunity

研究者

发起方
Amsterdam UMC

相似试验